Suppr超能文献

部分回肠旁路手术治疗杂合子家族性高胆固醇血症:综述

Partial ileal bypass surgery in the treatment of heterozygous familial hypercholesterolemia: a review.

作者信息

Schouten J A, Beynen A C

出版信息

Artery. 1986;13(4):240-63.

PMID:3518666
Abstract

Partial ileal bypass (PIB) surgery is a method in the treatment of heterozygous familial hypercholesterolemia (FH). Since the first report in 1964 about 150 cases of FH who underwent the surgical procedure have been described. This number is very low when compared to other types of cholesterol-lowering treatment. On average, PIB decreases the level of plasma total cholesterol by 35% in FH patients, and the surgical procedure can be considered the most effective, single cholesterol-lowering method. PIB-induced reduction of plasma cholesterol is permanent. Further decrease of plasma cholesterol may be obtained in combination with an inhibitor of cholesterol biosynthesis. PIB specifically lowers plasma LDL cholesterol; the concentration of HDL cholesterol is not systematically influenced. The mechanism underlying the hypocholesterolemic action of PIB is discussed. Until now there is no evidence that PIB reduces atherosclerotic coronary death in FH patients. After PIB more patients experience improvement of angina pectoris rather than deterioration (15 versus 2 out of 41), but the number of patients is too small to allow solid conclusions. In 50% of FH patients PIB may cause regression of xanthomata. Out of 209 hyperlipidemic patients described, 14 patients had postoperative complications, which caused death in 3 patients. Diarrhea is the most common side-effect of PIB; out of 99 operated patients serious diarrhea troubled 38 patients, whereas 40 patients had minor complaints during the first year postoperatively. Diarrhea may persist as long as 10 years after PIB. There is no evidence that PIB enhances gallstone formation and severely impairs liver function, but PIB may increase the incidence of renal stones. It is suggested that PIB can be considered in the treatment of FH. However, in each individual case the disadvantages and possible advantages should be carefully weighed out, and this consideration should form the basis to decide whether or not surgery is indicated.

摘要

部分回肠旁路术(PIB)是治疗杂合子家族性高胆固醇血症(FH)的一种方法。自1964年首次报道以来,已描述了约150例接受该手术的FH患者。与其他类型的降胆固醇治疗相比,这个数字非常低。平均而言,PIB可使FH患者的血浆总胆固醇水平降低35%,该手术可被认为是最有效的单一降胆固醇方法。PIB引起的血浆胆固醇降低是永久性的。联合胆固醇生物合成抑制剂可进一步降低血浆胆固醇。PIB特异性降低血浆低密度脂蛋白胆固醇;高密度脂蛋白胆固醇的浓度没有受到系统性影响。讨论了PIB降胆固醇作用的潜在机制。到目前为止,没有证据表明PIB能降低FH患者的动脉粥样硬化性冠状动脉死亡风险。PIB术后更多患者的心绞痛症状得到改善而非恶化(41例中有15例改善,2例恶化),但患者数量太少,无法得出确凿结论。50%的FH患者PIB后可能出现黄瘤消退。在描述的209例高脂血症患者中,14例有术后并发症,其中3例死亡。腹泻是PIB最常见的副作用;99例接受手术的患者中,38例出现严重腹泻,40例在术后第一年有轻微不适。腹泻可能在PIB后持续长达10年。没有证据表明PIB会增加胆结石形成和严重损害肝功能,但PIB可能增加肾结石的发生率。建议可考虑用PIB治疗FH。然而,在每个具体病例中,应仔细权衡其弊端和可能的益处,这种考虑应作为决定是否进行手术的依据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验